» Articles » PMID: 25831126

Changes to Serum Sample Tube and Processing Methodology Does Not Cause Intra-Individual [corrected] Variation in Automated Whole Serum N-glycan Profiling in Health and Disease

Overview
Journal PLoS One
Date 2015 Apr 2
PMID 25831126
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Serum N-glycans have been identified as putative biomarkers for numerous diseases. The impact of different serum sample tubes and processing methods on N-glycan analysis has received relatively little attention. This study aimed to determine the effect of different sample tubes and processing methods on the whole serum N-glycan profile in both health and disease. A secondary objective was to describe a robot automated N-glycan release, labeling and cleanup process for use in a biomarker discovery system.

Methods: 25 patients with active and quiescent inflammatory bowel disease and controls had three different serum sample tubes taken at the same draw. Two different processing methods were used for three types of tube (with and without gel-separation medium). Samples were randomised and processed in a blinded fashion. Whole serum N-glycan release, 2-aminobenzamide labeling and cleanup was automated using a Hamilton Microlab STARlet Liquid Handling robot. Samples were analysed using a hydrophilic interaction liquid chromatography/ethylene bridged hybrid(BEH) column on an ultra-high performance liquid chromatography instrument. Data were analysed quantitatively by pairwise correlation and hierarchical clustering using the area under each chromatogram peak. Qualitatively, a blinded assessor attempted to match chromatograms to each individual.

Results: There was small intra-individual variation in serum N-glycan profiles from samples collected using different sample processing methods. Intra-individual correlation coefficients were between 0.99 and 1. Unsupervised hierarchical clustering and principal coordinate analyses accurately matched samples from the same individual. Qualitative analysis demonstrated good chromatogram overlay and a blinded assessor was able to accurately match individuals based on chromatogram profile, regardless of disease status.

Conclusions: The three different serum sample tubes processed using the described methods cause minimal inter-individual variation in serum whole N-glycan profile when processed using an automated workstream. This has important implications for N-glycan biomarker discovery studies using different serum processing standard operating procedures.

Citing Articles

Automated high throughput IgG N-glycosylation sample preparation method development on the Tecan Freedom EVO platform.

Rapcan B, Hanic M, Plavsa B, Simunovic J, Stambuk J, Vuckovic F Biochem Med (Zagreb). 2024; 34(2):020708.

PMID: 38882586 PMC: 11177659. DOI: 10.11613/BM.2024.020708.


Influence of plasma collection tubes on N-glycome in human blood samples.

Zhang Z, Cui X, Zhou N, Zhu L, Zhi Y, Zhang S Pract Lab Med. 2024; 39:e00383.

PMID: 38463195 PMC: 10924059. DOI: 10.1016/j.plabm.2024.e00383.


Sialic Acid Derivatization of Fluorescently Labeled -Glycans Allows Linkage Differentiation by Reversed-Phase Liquid Chromatography-Fluorescence Detection-Mass Spectrometry.

Moran A, Gardner R, Wuhrer M, Lageveen-Kammeijer G, Spencer D Anal Chem. 2022; 94(18):6639-6648.

PMID: 35482581 PMC: 9096788. DOI: 10.1021/acs.analchem.1c02610.


Imidazolium labelling permits the sensitive mass-spectrometric detection of -glycosides directly from serum.

Zhang Y, Ghirardello M, Wang T, Lu A, Liu L, Voglmeir J Chem Commun (Camb). 2021; 57(57):7003-7006.

PMID: 34159978 PMC: 8280963. DOI: 10.1039/d1cc02100a.


A novel glycosidase plate-based assay for the quantification of galactosylation and sialylation on human IgG.

Rebello O, Gardner R, Urbanowicz P, Bolam D, Crouch L, Falck D Glycoconj J. 2020; 37(6):691-702.

PMID: 33064245 PMC: 7679266. DOI: 10.1007/s10719-020-09953-9.


References
1.
Pucic M, Pinto S, Novokmet M, Knezevic A, Gornik O, Polasek O . Common aberrations from the normal human plasma N-glycan profile. Glycobiology. 2010; 20(8):970-5. DOI: 10.1093/glycob/cwq052. View

2.
Bowen R, Hortin G, Csako G, Otanez O, Remaley A . Impact of blood collection devices on clinical chemistry assays. Clin Biochem. 2009; 43(1-2):4-25. DOI: 10.1016/j.clinbiochem.2009.10.001. View

3.
Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, Polasek O . High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics. 2011; 10(10):M111.010090. PMC: 3205872. DOI: 10.1074/mcp.M111.010090. View

4.
Cuhadar S, Atay A, Koseoglu M, Dirican A, Hur A . Stability studies of common biochemical analytes in serum separator tubes with or without gel barrier subjected to various storage conditions. Biochem Med (Zagreb). 2012; 22(2):202-14. PMC: 4062343. DOI: 10.11613/bm.2012.023. View

5.
Ercan A, Cui J, Hazen M, Batliwalla F, Royle L, Rudd P . Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. Arthritis Res Ther. 2012; 14(2):R43. PMC: 3446410. DOI: 10.1186/ar3756. View